Clinical Trial Update: Safety and Efficacy of Hunterase [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Hunterase for mucopolysaccharidosis type II has completed; results are not disclosed in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Hunterase (Idursulfase Beta)

Snippet

Sponsor: Green Cross Corporation | Conditions: Hunter Syndrome | Phase 3 | Status: COMPLETED